BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 9431830)

  • 1. Characterization of the human cytochrome P450 enzymes involved in the metabolism of dihydrocodeine.
    Kirkwood LC; Nation RL; Somogyi AA
    Br J Clin Pharmacol; 1997 Dec; 44(6):549-55. PubMed ID: 9431830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydrocodeine: a new opioid substrate for the polymorphic CYP2D6 in humans.
    Fromm MF; Hofmann U; Griese EU; Mikus G
    Clin Pharmacol Ther; 1995 Oct; 58(4):374-82. PubMed ID: 7586928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes.
    Lalovic B; Phillips B; Risler LL; Howald W; Shen DD
    Drug Metab Dispos; 2004 Apr; 32(4):447-54. PubMed ID: 15039299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes.
    Hutchinson MR; Menelaou A; Foster DJ; Coller JK; Somogyi AA
    Br J Clin Pharmacol; 2004 Mar; 57(3):287-97. PubMed ID: 14998425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man.
    Venkatakrishnan K; von Moltke LL; Duan SX; Fleishaker JC; Shader RI; Greenblatt DJ
    J Pharm Pharmacol; 1998 Mar; 50(3):265-74. PubMed ID: 9600717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone N-deethylation in human liver microsomes: involvement of cytochrome P450 3A enzymes (first report).
    Trivier JM; Libersa C; Belloc C; Lhermitte M
    Life Sci; 1993; 52(10):PL91-6. PubMed ID: 8445979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of dextromethorphan in vitro: involvement of cytochromes P450 2D6 and 3A3/4, with a possible role of 2E1.
    Schmider J; Greenblatt DJ; Fogelman SM; von Moltke LL; Shader RI
    Biopharm Drug Dispos; 1997 Apr; 18(3):227-40. PubMed ID: 9113345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsomal codeine N-demethylation: cosegregation with cytochrome P4503A4 activity.
    Caraco Y; Tateishi T; Guengerich FP; Wood AJ
    Drug Metab Dispos; 1996 Jul; 24(7):761-4. PubMed ID: 8818573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative contribution to dextromethorphan metabolism by cytochrome P450 isoforms in vitro: can dextromethorphan be used as a dual probe for both CTP2D6 and CYP3A activities?
    Yu A; Haining RL
    Drug Metab Dispos; 2001 Nov; 29(11):1514-20. PubMed ID: 11602530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-Dealkylation of fluoxetine in relation to CYP2C19 gene dose and involvement of CYP3A4 in human liver microsomes.
    Liu ZQ; Zhu B; Tan YF; Tan ZR; Wang LS; Huang SL; Shu Y; Zhou HH
    J Pharmacol Exp Ther; 2002 Jan; 300(1):105-11. PubMed ID: 11752104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro cytochrome P450 dependent metabolism of oxybutynin to N-deethyloxybutynin in humans.
    Yaïch M; Popon M; Médard Y; Aigrain EJ
    Pharmacogenetics; 1998 Oct; 8(5):449-51. PubMed ID: 9825837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes.
    Ekström G; Gunnarsson UB
    Drug Metab Dispos; 1996 Sep; 24(9):955-61. PubMed ID: 8886604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine.
    Zhang H; Coville PF; Walker RJ; Miners JO; Birkett DJ; Wanwimolruk S
    Br J Clin Pharmacol; 1997 Mar; 43(3):245-52. PubMed ID: 9088578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative metabolism of clarithromycin in the presence of human liver microsomes. Major role for the cytochrome P4503A (CYP3A) subfamily.
    Rodrigues AD; Roberts EM; Mulford DJ; Yao Y; Ouellet D
    Drug Metab Dispos; 1997 May; 25(5):623-30. PubMed ID: 9152603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary and secondary oxidative metabolism of dextromethorphan. In vitro studies with female Sprague-Dawley and Dark Agouti rat liver microsomes.
    Kerry NL; Somogyi AA; Mikus G; Bochner F
    Biochem Pharmacol; 1993 Feb; 45(4):833-9. PubMed ID: 8452558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro.
    Bakken GV; Molden E; Knutsen K; Lunder N; Hermann M
    Drug Metab Dispos; 2012 Sep; 40(9):1778-84. PubMed ID: 22688609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan: relationship to the presence of immunoidentified cytochrome P-450IID1.
    Mortimer O; Persson K; Ladona MG; Spalding D; Zanger UM; Meyer UA; Rane A
    Clin Pharmacol Ther; 1990 Jan; 47(1):27-35. PubMed ID: 2295216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation.
    Jones DR; Gorski JC; Hamman MA; Mayhew BS; Rider S; Hall SD
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1116-25. PubMed ID: 10454485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interactions of a selective protein kinase C beta inhibitor with the human cytochromes P450.
    Ring BJ; Gillespie JS; Binkley SN; Campanale KM; Wrighton SA
    Drug Metab Dispos; 2002 Sep; 30(9):957-61. PubMed ID: 12167559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4--implications for susceptibility to Parkinson's disease.
    Coleman T; Ellis SW; Martin IJ; Lennard MS; Tucker GT
    J Pharmacol Exp Ther; 1996 May; 277(2):685-90. PubMed ID: 8627546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.